Page 239 - Keterangan Pers Kepala Badan POM dan Juru Bicara Satgas Penanganan COVID-19 di Istana Kepresidenan Jakarta

In another vaccine development effort, state-owned drugmaker Kimia Farma is
collaborating with the China National Pharmaceutical Group Corp.
(Sinopharm) and G42 Healthcare, a subsidiary of the Abu Dhabi-based artificial
intelligence company Group 42 (G42). The United Arab Emirates government has
reportedly promised to provide a supply of at least 10 million doses of the
Sinopharm vaccine to Indonesia by the end of the year.

The BPOM made an official visit to the UAE on Aug. 24 to 26 to obtain details
of the vaccine, which has been certified as halal and has also received authorization
for emergency use from China's National Medical Products Administration (NMPA).

Penny said that the BPOM would join Sinopharm and G42 in evaluating the safety
and effectiveness of the final vaccine.

The agency would also ensure the transfer of vaccine technology from foreign
producers to Indonesian firms for future development of locally made vaccines, she
added.